Dr. Khalil Diab, MD
Claim this profileGW Medical Faculty Associates
Studies Alpha-1 Antitrypsin Deficiency
Studies Emphysema
3 reported clinical trials
4 drugs studied
Area of expertise
1Alpha-1 Antitrypsin Deficiency
SERPINA1 positive
SERPINA1 negative
2Emphysema
Affiliated Hospitals
GW Medical Faculty Associates
The George Washington University Hospital
Clinical Trials Khalil Diab, MD is currently running
Alpha1-Proteinase Inhibitor
for Alpha-1 Antitrypsin Deficiency
This trial tests if Alpha-1 protein injections are safe and tolerable for people with Alpha1-Antitrypsin Deficiency. The treatment aims to protect their lungs by giving them extra Alpha-1 protein. Alpha-1 proteinase inhibitor, a human-derived blood product, has been used for over 20 years to treat individuals with Alpha1-Antitrypsin Deficiency.
Recruiting1 award Phase 1 & 24 criteria
INBRX-101 vs Zemaira
for Emphysema
Phase 2 study to compare INBRX-101 to plasma derived A1PI therapy in adults with AATD emphysema
Recruiting1 award Phase 25 criteria
More about Khalil Diab, MD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Khalil Diab, MD has experience with
- INBRX-101
- Zemaira
- Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy
- Alpha-1 15%
Breakdown of trials Khalil Diab, MD has run
Alpha-1 Antitrypsin Deficiency
Emphysema
Lymphadenopathy
Mediastinal Diseases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Khalil Diab, MD specialize in?
Khalil Diab, MD focuses on Alpha-1 Antitrypsin Deficiency and Emphysema. In particular, much of their work with Alpha-1 Antitrypsin Deficiency has involved SERPINA1 positive patients, or patients who are SERPINA1 negative.
Is Khalil Diab, MD currently recruiting for clinical trials?
Yes, Khalil Diab, MD is currently recruiting for 3 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Khalil Diab, MD has studied deeply?
Yes, Khalil Diab, MD has studied treatments such as INBRX-101, Zemaira, Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy.
What is the best way to schedule an appointment with Khalil Diab, MD?
Apply for one of the trials that Khalil Diab, MD is conducting.
What is the office address of Khalil Diab, MD?
The office of Khalil Diab, MD is located at: GW Medical Faculty Associates, Washington, District of Columbia 20037 United States. This is the address for their practice at the GW Medical Faculty Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.